Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 27166 AL 27180

The involvement of HIF-1α-dependent paracrine factors in Alzheimer's disease

Zhdankina VI, Perepelitsa ES, Blagova AV, Komleva YK, Baranich TI, Salmina AB.

Rev Neurosci. 2025 Oct 7;37(1):61-75. doi: 10.1515/revneuro-2025-0102. Print 2026 Jan 23.

[Disease-modifying therapy with lecanemab for early Alzheimer's dementia]

Hansen N, Wiltfang J.

Fortschr Neurol Psychiatr. 2025 Nov;93(11):453-460. doi: 10.1055/a-2681-4558. Epub 2025 Oct 6.

Astrocyte response in Alzheimer's disease: Good or bad?

Ismail A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Yassen ASA, Alexiou A, Papadakis M, Batiha GE.

Brain Res. 2025 Dec 1;1868:149971. doi: 10.1016/j.brainres.2025.149971. Epub 2025 Oct 6.

The rhythm of decline: Circadian disruption in neurodegeneration

Singh J, Kumar D, Kaur J, Singh A.

J Food Drug Anal. 2025 Sep 18;33(3):224-240. doi: 10.38212/2224-6614.3553.

Brain somatic mutations in Alzheimer's disease: linking genetic mosaicism to neurodegeneration

Li Z, Zhang J, Liu Z, Yu L, Yang C, Zhang L, Xiang Z, Hu F, Brazh N, Shu K, Zhu LQ, Liu D.

Mol Neurodegener. 2025 Oct 9;20(1):104. doi: 10.1186/s13024-025-00895-0.

Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of alzheimer's disease

Chen J, Zhang X, Sun J, Zhi Y, Xie Z, Guan Y, Zhang Z, Wu C.

J Nanobiotechnology. 2025 Oct 10;23(1):650. doi: 10.1186/s12951-025-03709-z.

Tau-Targeted Therapeutic Strategies: Mechanistic Targets, Clinical Pipelines, and Analysis of Failures

Shen X, Li H, Zhang B, Li Y, Zhu Z.

Cells. 2025 Sep 26;14(19):1506. doi: 10.3390/cells14191506.

Targeting Oligodendrocyte Dysfunction in Alzheimer's Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists

Gurikar S, Ahmed SS, Raghunatahanaidu BD.

J Mol Neurosci. 2025 Oct 15;75(4):139. doi: 10.1007/s12031-025-02433-5.

Gene-Exercise Interactions in Amyloid Metabolism and Clearance: Implications for Alzheimer's Disease

Astorino MF, Cipriano GL, Anchesi I, Lui M, Raffaele I, Calabrò M, Crisafulli C.

Int J Mol Sci. 2025 Oct 9;26(19):9816. doi: 10.3390/ijms26199816.

Nutraceuticals intervention in Alzheimer's disease: From farm to pharma

Chaithra PM, Rakshith BS, Logesh S, Kanthesh BM, Gopenath TS, Chang HM, Perry G, Singh SK.

J Alzheimers Dis. 2025 Dec;108(3):969-996. doi: 10.1177/13872877251385216. Epub 2025 Oct 17.

The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer's disease

Xu Y, Li X, Zhao Q, Xu X.

Ann Med. 2025 Dec;57(1):2575110. doi: 10.1080/07853890.2025.2575110. Epub 2025 Oct 24.

Expanding the scope of olfactory evaluation in Alzheimer's disease and related dementias (ADRD): A narrative review of the role for odor memory and recognition in AD/ADRD

Saak TM, Tervo JP, Motter JN, Overdevest JB.

J Alzheimers Dis. 2026 Mar;110(1_suppl):S68-S82. doi: 10.1177/13872877251389113. Epub 2025 Oct 27.

Cell Therapy Is a New Treatment Option to Prevent Neurodegenerative Changes and Restore Cognitive Functions in Alzheimer's Disease (Review)

Voronova AD, Karsuntseva EK, Shishkina VS, Fursa GA, Chadin AV, Shport SV, Stepanova OV, Chekhonin VP.

Bull Exp Biol Med. 2025 Aug;179(4):507-517. doi: 10.1007/s10517-025-06519-3. Epub 2025 Nov 4.

Amyloid-β as a cytokine-like somnogen: Rethinking its role in sleep homeostasis and Alzheimer's disease

Fernandez FX, Grandner MA.

J Alzheimers Dis. 2026 Jan;109(1):70-83. doi: 10.1177/13872877251392186. Epub 2025 Nov 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias